A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration.
about
American Cancer Society Colorectal Cancer Survivorship Care GuidelinesAntineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityHerbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study.Impact of oxaliplatin-induced neuropathy in patients with colorectal cancer: a prospective evaluation at a single institution.Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review.Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity.Contribution of Piezo2 to endothelium-dependent pain.Duloxetine Protects against Oxaliplatin-Induced Neuropathic Pain and Spinal Neuron Hyperexcitability in Rodents.Long-Term and Latent Side Effects of Specific Cancer Types.Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life.Chronic Pain and Neuropathy Following Adjuvant Chemotherapy.Oxaliplatin-induced Peripheral Neuropathy in South Indian Cancer Patients: A Prospective Study in Digestive Tract Cancer Patients.A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy.Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study.Reliability testing of oxaliplatin-associated neurotoxicity questionnaire (OANQ), a pilot study.The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review.Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity.Hyperacute peripheral neuropathy is a predictor of oxaliplatin-induced persistent peripheral neuropathy.Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up studyDevelopment and Validation of a Simple and Selective Analytical HPLC Method for the Quantification of Oxaliplatin
P2860
Q26782671-66696448-0A61-4E6B-9478-D222DD657A9BQ27305830-1865EA0F-7DF6-4985-9E2A-2C129924EFDEQ33770708-B74850A4-25F6-4BE0-8E4C-E9D3AB299140Q35331858-60B4116E-8D75-452E-9D84-0DC032F3CC91Q36129089-8B62DFEC-D118-4966-8EAA-05C3766D8887Q36581502-EC51FB85-6547-4BFD-AC20-61FD68E7B2AFQ36932675-3379B288-37AD-416C-8D72-800220B9B419Q37634989-D6AD313C-D879-4D32-982B-342E1A6C6F52Q37662576-94166B60-F80A-4D61-87E8-2CD015F6FA39Q38228522-10ED2F6B-749C-4E2E-97A4-D44840D5A750Q38707400-12455122-51C0-415F-A9AD-5B84484868D1Q39095046-1CBE24A8-E779-42E6-A65B-4518E7C9040EQ42361420-448EB1FC-DA97-4A28-AFF6-7C558C2822D0Q47097584-D5DB0FC9-12E8-4B1B-835D-2F7F4DA6BDE9Q47268054-F82E97C6-A359-4C32-9B73-577679C745B6Q47602301-4B127EF2-45CF-48FD-BF5F-78A9E840C410Q47670602-5BBCC37D-627B-4D5A-937C-A9D5F1501A4BQ47894849-C5C4AC6D-B6CE-462E-9DA7-385904EA14DCQ49439093-6421BA5E-1F27-4497-8505-43D70ED153AAQ49520475-A297C32F-FAAB-490E-9606-55E2AB509A28Q50103900-BC36DCFD-2149-4E03-9911-08BE84BB4D56Q50540769-FB909878-36C4-4ED7-A814-4348C06BB42FQ52591422-FD33943B-8570-4832-9E03-41374F00471FQ52648842-383C7257-240C-4595-A766-DC1DB4C70900Q53645807-7FA1CB5F-0179-4CDD-8105-F50DE0552FCEQ58874339-EC11EC35-D500-4987-8931-CB3546FE5DB0Q59112563-F0BAC6E9-1A93-4727-9879-E9E4FFAE1D9E
P2860
A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review on chronic ...... th oxaliplatin administration.
@en
type
label
A systematic review on chronic ...... th oxaliplatin administration.
@en
prefLabel
A systematic review on chronic ...... th oxaliplatin administration.
@en
P2093
P2860
P1476
A systematic review on chronic ...... th oxaliplatin administration.
@en
P2093
A J M Beijers
G Vreugdenhil
P2860
P2888
P304
P356
10.1007/S00520-014-2242-Z
P577
2014-04-13T00:00:00Z